Drugs / Mablet
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02216877 | Aug 2014 → Apr 2015 | chronic kidney disease, magnesium deficiency | Zealand University Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mablet | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02216877 ↗ |
| Route | Oral | “Oral Mablet 360 mg once daily and oral placebo once daily for 8 weeks.” NCT02216877 ↗ |